Jack Anders
Chief Financial Officer · 4 filings · Latest: Jun 24, 2026
Revolution Medicines, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
RVMD | Jack Anders | Chief Financial Officer | Jun 24, 2026 | Sale | $168.33 | 20,000 | $3.4M | 123,269 | |
RVMD | Jack Anders | Chief Financial Officer | Jun 24, 2026 | Option Exercise | $18.56 | 20,000 | $371.2K | 143,269 | |
RVMD | JACK ANDERS | — | Jun 24, 2026 | Proposed Sale | $169.51 | 20,000 | $3.4M | — | |
RVMD | Jack Anders | Chief Financial Officer | Jun 16, 2026 | Sale | $156.12 | 2,722 | $425.0K | 123,269 | |
RVMD | Anders Jack | — | Jun 15, 2026 | Proposed Sale | $153.87 | 2,653 | $408.2K | — | |
RVMD | Jack Anders | Chief Financial Officer | Mar 17, 2026 | Sale | $99.48 | 2,753 | $273.9K | 125,512 | |
RVMD | Anders Jack | — | Mar 16, 2026 | Proposed Sale | $99.59 | 2,134 | $212.5K | — | |
RVMD | JACK LEE ANDERS | — | Jan 7, 2026 | Proposed Sale | $79.85 | 10,000 | $798.5K | — | |
RVMD | Anders Jack | — | Dec 15, 2025 | Proposed Sale | $77.81 | 3,017 | $234.8K | — | |
RVMD | JACK LEE ANDERS | — | Nov 25, 2025 | Proposed Sale | $73.66 | 5,418 | $399.1K | — | |
RVMD | JACK LEE ANDERS | — | Nov 11, 2025 | Proposed Sale | $62.73 | 10,000 | $627.3K | — | |
RVMD | Anders Jack | — | Sep 15, 2025 | Proposed Sale | $46.55 | 2,128 | $99.1K | — | |
RVMD | JACK LEE ANDERS | — | Sep 2, 2025 | Proposed Sale | $37.97 | 10,000 | $379.7K | — | |
RVMD | Anders Jack | — | Jun 16, 2025 | Proposed Sale | $40.79 | 2,127 | $86.8K | — | |
RVMD | Anders Jack | — | Mar 17, 2025 | Proposed Sale | $38.89 | 2,108 | $82.0K | — | |
RVMD | Anders Jack | — | Dec 16, 2024 | Proposed Sale | $44.93 | 2,600 | $116.8K | — | |
RVMD | JACK LEE ANDERS | — | Oct 11, 2024 | Proposed Sale | $49.50 | 10,000 | $495.0K | — | |
RVMD | Anders Jack | — | Sep 16, 2024 | Proposed Sale | $42.12 | 1,832 | $77.2K | — | |
RVMD | Anders Jack | — | Sep 16, 2024 | Proposed Sale | $42.12 | 1,832 | $77.2K | — |